For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, CytomX Therapeutics Inc’s stock clocked out at $0.73, down -0.80% from its previous closing price of $0.74. In other words, the price has decreased by -$0.80 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
To gain a deeper understanding of CTMX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.25.
On May 28, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $2.25 to $3.50.
Wedbush Upgraded its Neutral to Outperform on May 09, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when McCarthy Sean A. sold 37,656 shares for $0.60 per share. The transaction valued at 22,556 led to the insider holds 995,195 shares of the business.
Ogden Christopher sold 8,551 shares of CTMX for $5,122 on Mar 18 ’25. The Chief Financial Officer now owns 201,026 shares after completing the transaction at $0.60 per share. On Mar 18 ’25, another insider, Chu Yu-Waye, who serves as the Chief Medical Officer of the company, sold 4,025 shares for $0.60 each. As a result, the insider received 2,411 and left with 135,725 shares of the company.
Valuation Measures:
As of this moment, CytomX’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42.
Stock Price History:
Over the past 52 weeks, CTMX has reached a high of $5.85, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 12.32%, while the 200-Day Moving Average is calculated to be -27.26%.
Shares Statistics:
A total of 80.10M shares are outstanding, with a floating share count of 78.13M. Insiders hold about 2.46% of the company’s shares, while institutions hold 58.22% stake in the company.
